Skip to main content

IMRAB + POTOMAVAC

This page contains information on IMRAB + POTOMAVAC for veterinary use.
The information provided typically includes the following:
  • IMRAB + POTOMAVAC Indications
  • Warnings and cautions for IMRAB + POTOMAVAC
  • Direction and dosage information for IMRAB + POTOMAVAC

IMRAB + POTOMAVAC

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Rabies Vaccine, Killed Virus

Neorickettsia Risticii Bacterin

PHF+Rabies

IMRAB + POTOMAVAC Indications

This product has been shown to be effective for the vaccination of healthy horses 3 months of age or older against rabies virus and potomac horse fever (PHF) (equine monocytic ehrlichiosis) due to Neorickettsia risticii. The duration of immunity against rabies is at least 1 year. The duration of immunity against PHF has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions and dosage: Shake well before use. For primary vaccination, aseptically administer one 1 mL dose intramuscularly into healthy horses. For N. risticii, administer a second dose 3 to 4 weeks later using this product or Potomavac. Contact your veterinarian or the manufacturer for information on revaccination frequency against N. risticii. Revaccinate against rabies annually with a single 1 mL dose.

Precautions

Store at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results. This product has not been tested in pregnant mares. In case of human exposure, contact a physician.

Preservatives: Gentamicin and thimerosal.

For use in animals only.

Restricted to use by or under the direction of a veterinarian.

Potomavac™ is a trademark in the USA of Boehringer Ingelheim Animal Health USA Inc.

Potomavac™ is a trademark in Canada of Boehringer Ingelheim Vetmedica GmbH, used under license.

Imrab® is a registered trademark of the Boehringer Ingelheim Group.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601

Phone: 1 (888) 637-4251

VLN/PCN 124/4905.20

Distributed in Canada by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

 

 

Prod. No.

 

5 DOSES

5 x 1 dose (1 mL)

2421-05

RM425R12

30 DOSES

3 x 10 doses (10 mL)

2420-03

RM424R11

CPN: 1028381.0

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone:   800-325-9167
Customer Service:   888-637-4251
Technical Service:   888-637-4251
Fax:   816-236-2717
Website:   www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27